Literature DB >> 7389751

Radioimmunoassay of bromperidol and haloperidol in human and canine plasma.

E Van Den Eeckhout, F M Belpaire, M G Bogaert, P De Moerloose.   

Abstract

In order to check the specificity of a radioimmunological assay for haloperidol and bromperidol reported by Michiels et al. (1) and commercialized by IRE (Fleurus, Belgium), the assay was performed on canine and human plasma samples with and without extraction. After a single dose of bromperidol in dogs, plasma levels obtained with and without extraction were similar. In man the plasma levels for bromperidol after a single administration were markedly lower after extraction. The same was true for haloperidol plasma levels after chronic dosing in man. The findings suggest that the direct radioimmunoassay of haloperidol or bromperidol with the commercialized kit, lacks specificity of humans, possibly because of the presence of one or more polar metabolites.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7389751     DOI: 10.1007/BF03189443

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  6 in total

1.  Plasma level profile of haloperidol in man following intramuscular administration.

Authors:  W A Cressman; J R Bianchine; V B Slotnick; P C Johnson; J Plostnieks
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

2.  Radioimmunoassay of haloperidol in human serum.

Authors:  B R Clark; B B Tower; R T Rubin
Journal:  Life Sci       Date:  1977-01-15       Impact factor: 5.037

3.  Pharmacokinetic studies on haloperidol in man.

Authors:  A Forsman; R Ohman
Journal:  Curr Ther Res Clin Exp       Date:  1976-09

4.  Analytical methods for the determination of bromperidol in plasma.

Authors:  E Van den Eeckhout; F Belpaire
Journal:  Acta Psychiatr Belg       Date:  1978 Jan-Feb

5.  Distribution excretion and metabolism of neuroleptics of the butyrophenone type. II. Distribution, excretion and metabolism of haloperidol in Sprague-Dawley rats.

Authors:  G A Braun; G I Poos; W Soudijn
Journal:  Eur J Pharmacol       Date:  1967-01       Impact factor: 4.432

6.  Metabolic fate of bromperidol in humans: comparison with rats and dogs.

Authors:  L F Chasseaud
Journal:  Acta Psychiatr Belg       Date:  1978 Jan-Feb
  6 in total
  3 in total

Review 1.  Bromperidol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in psychoses.

Authors:  P Benfield; A Ward; B G Clark; S G Jue
Journal:  Drugs       Date:  1988-06       Impact factor: 9.546

2.  Bromperidol, a new butyrophenone neuroleptic: a review.

Authors:  B Dubinsky; J L McGuire; C J Niemegeers; P A Janssen; H S Weintraub; B E McKenzie
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

3.  Antiemetic effect of haloperidol in the dog as related to plasma level and dose.

Authors:  C J Niemegeers; J J Heykants; P A Janssen
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.